Polymyxin B For Injection Usp 500000 Iu Dry Powder Injections Vial

What is Polymyxin B For Injection USP 500000 IU?

Polymyxin B For Injection USP 500000 IU is a dry powder injectable antibiotic containing polymyxin B. It belongs to the polymyxin class of antibacterial agents and is used in selected clinical situations involving susceptible Gram-negative bacteria. Due to its potential for serious adverse effects, treatment requires careful medical supervision, appropriate patient monitoring and confirmation of the approved product information.

Uses and Indications

Polymyxin B is an antibacterial medicine reserved for selected serious infections caused by susceptible bacteria, particularly certain Gram-negative organisms.

Depending on the approved product information and local clinical guidance, it may be considered for:

• Selected serious Gram-negative bacterial infections.

• Infections caused by susceptible organisms when other suitable antibiotics may be ineffective or inappropriate.

• Specialist-directed treatment where susceptibility results and clinical assessment support its use.

The precise approved indications for this injectable product must be verified against its product documentation.

Potential Benefits

• Targeted antibacterial activity: Acts against certain susceptible Gram-negative bacteria.

• Specialist treatment option: May be considered for selected serious infections under appropriate clinical supervision.

• Defined product strength: Supplied strength is identified as 500000 IU.

• International sourcing support: Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries for international buyers.

Side Effects

Polymyxin B can cause significant adverse effects. Its use requires an appropriate benefit–risk assessment.

Potential adverse effects include:

• Kidney toxicity, including changes in renal function.

• Neurological effects, such as tingling, dizziness or muscle weakness.

• Neuromuscular blockade, which may affect breathing.

• Hypersensitivity reactions.

• Local or infusion-related reactions, depending on the administration method.

Serious symptoms, particularly breathing difficulty, marked muscle weakness or reduced urine output, require urgent medical assessment.

How Does Polymyxin B Work?

Polymyxin B acts by interacting with components of the bacterial cell membrane, disrupting membrane integrity and causing leakage of cellular contents. This antibacterial mechanism is active against certain Gram-negative organisms. Activity depends on the susceptibility of the organism, and laboratory susceptibility results may be important when selecting treatment.

Dosage Guidelines

• Supplied strength: 500000 IU.

• The prescribed dose, dosing interval and treatment duration depend on the infection, patient characteristics, renal function, clinical guidance and approved product information.

• Preparation and administration must follow the product-specific instructions.

• Treatment should be prescribed and supervised by an appropriately qualified healthcare professional.

Do not infer a dose, route, reconstitution volume, diluent or infusion rate from the vial strength alone. These details must be verified against the approved product documentation and applicable clinical guidance.

When Not to Use

Polymyxin B may be unsuitable for patients with:

• Known hypersensitivity to polymyxin B or any formulation component.

• A contraindication specified in the approved product information.

• Clinical circumstances in which its toxicity risks outweigh the expected benefits.

Renal impairment, neuromuscular disorders and other relevant conditions require particular clinical assessment before treatment.

Drug and Product Interactions

Polymyxin B may interact with medicines that affect kidney function or neuromuscular transmission.

Examples requiring careful review include:

• Other nephrotoxic medicines: May increase the risk of kidney injury.

• Neuromuscular-blocking agents: May increase the risk of neuromuscular blockade.

• Certain anaesthetic agents: May contribute to neuromuscular effects.

• Other potentially neurotoxic medicines: May increase the need for monitoring.

A healthcare professional should review all concurrent medicines. Physical compatibility with other injectable products must be confirmed separately; medicines should not be mixed unless compatibility is documented.

Safety Advice

• Use only under qualified medical supervision.

• Monitor renal function and other relevant clinical parameters as directed by the treating team.

• Report muscle weakness, breathing difficulty, unusual tingling or reduced urine output promptly.

• Inform the healthcare professional about existing kidney problems, neuromuscular disorders and all medicines being taken.

• Do not use a vial if its identity, integrity or packaging is compromised.

General Instructions

• Verify the product name, strength and approved product documentation before use.

• Follow the specified preparation, handling and administration instructions.

• Do not assume compatibility with other injectable medicines.

• Use appropriate clinical monitoring throughout treatment.

• Confirm product-specific details against the approved product specification.

Special Dietary and Lifestyle Tips

There is no universal diet that treats a serious bacterial infection. General supportive measures may include:

• Maintain hydration as advised by the treating healthcare professional, particularly where kidney function is a concern.

• Follow the prescribed treatment plan and attend recommended monitoring appointments.

• Inform the treating team about non-prescription medicines and supplements.

• Avoid starting additional medicines without checking for possible interactions.

• Complete the prescribed treatment course unless the treating healthcare professional changes the plan.

Comparison with Other Treatments

Antibiotic selection should be guided by infection severity, culture and susceptibility results where available, patient factors and applicable clinical guidance.

Precautions and Warnings

• Polymyxin B can cause serious renal and neurological adverse effects.

• Appropriate monitoring should be determined by the treating healthcare professional.

• Confirm the correct dosing units and preparation instructions before administration.

• Do not substitute polymyxin B for colistin or another polymyxin on a unit-for-unit basis.

• Antibacterial treatment should be based on clinical assessment and susceptibility information when available.

• Use must follow the applicable approved product information and local requirements.

Can I Use It With Other Medicines or Antibiotics?

Polymyxin B may be used as part of a specialist-directed treatment plan in selected circumstances, but concurrent medicines require careful review.

• The treating healthcare professional should assess potential kidney toxicity and neuromuscular interactions.

• Do not combine antibiotics or mix injectable products without an appropriate clinical rationale and verified compatibility.

• Antibiotic combinations should be selected according to the infection, susceptibility data and current clinical guidance.

Storage

Store Polymyxin B For Injection USP 500000 IU according to the approved product label and manufacturer’s instructions. The specific storage temperature, protection requirements, shelf life after reconstitution and in-use stability have not been provided and should not be assumed.

Frequently Asked Questions

1. What is Polymyxin B For Injection USP 500000 IU?

It is a dry powder injectable antibiotic containing polymyxin B, used for selected serious infections caused by susceptible bacteria.

2. What is the supplied strength?

The supplied strength is 500000 IU.

3. What type of bacteria does polymyxin B target?

It acts against certain susceptible Gram-negative bacteria. The suitability of treatment depends on the organism and its susceptibility.

4. Does polymyxin B require medical monitoring?

Yes. Because of potential kidney and neurological toxicity, treatment requires medical supervision and appropriate monitoring.

5. Can polymyxin B be used with other antibiotics?

It may be used in selected treatment plans, but the combination must be assessed by a qualified healthcare professional.

6. Is polymyxin B interchangeable with colistin?

No. They have different pharmacological and dosing considerations and should not be substituted on a unit-for-unit basis.

7. Can international buyers enquire about this product through Kelar Pharmachem India?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Availability, packing, documentation and supply terms can be confirmed on request.